nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
|
Wang, Fei |
|
2015 |
64 |
8 |
p. 965-976 |
artikel |
2 |
CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
|
Wang, Fei |
|
|
64 |
8 |
p. 965-976 |
artikel |
3 |
Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis
|
Zivancevic-Simonovic, Snezana |
|
2015 |
64 |
8 |
p. 1011-1019 |
artikel |
4 |
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
|
Maeda, Yoshinari |
|
2015 |
64 |
8 |
p. 1047-1056 |
artikel |
5 |
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
|
Balint, Joseph P. |
|
2015 |
64 |
8 |
p. 977-987 |
artikel |
6 |
Hepatic myeloid-derived suppressor cells in cancer
|
Medina-Echeverz, José |
|
2015 |
64 |
8 |
p. 931-940 |
artikel |
7 |
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
|
McCann, Katy J. |
|
2015 |
64 |
8 |
p. 1021-1032 |
artikel |
8 |
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation
|
Binsfeld, Marilène |
|
2015 |
64 |
8 |
p. 989-998 |
artikel |
9 |
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
|
Danielli, Riccardo |
|
|
64 |
8 |
p. 999-1009 |
artikel |
10 |
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
|
Danielli, Riccardo |
|
2015 |
64 |
8 |
p. 999-1009 |
artikel |
11 |
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
|
Muto, Masato |
|
2015 |
64 |
8 |
p. 941-949 |
artikel |
12 |
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
|
Sarkar, Subhashis |
|
2015 |
64 |
8 |
p. 951-963 |
artikel |
13 |
Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain
|
Anel, Alberto |
|
2015 |
64 |
8 |
p. 1067-1069 |
artikel |
14 |
Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain
|
Anel, Alberto |
|
|
64 |
8 |
p. 1067-1069 |
artikel |
15 |
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
|
Wang, Zili |
|
2015 |
64 |
8 |
p. 1057-1066 |
artikel |
16 |
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
|
Jeanbart, Laura |
|
2015 |
64 |
8 |
p. 1033-1046 |
artikel |